NVO · NYSE · Drug Manufacturers - General

Novo Nordisk (ADR) (NVO)

Develops GLP-1 and insulin medicines for diabetes, obesity and rare diseases.

$39.78
vs last close−0.02 (−0.06%)

Dividend yield
4.51%
Next ex-date
Feb 17, 27
estimated · in 148 days
Annual dividend
$1.80
per share
Schedule
Semi-annual
2 payments a year

Per share, Mar 2023 to Aug 2026DividendAnnual yield

Mar '23Aug '23Mar '24Aug '24Mar '25Aug '25Mar '26Aug '26
Dividend$0.5903$0.4382$0.9293$0.5169$1.1426$0.5843$1.2174$0.5792
Annual yield1.15%1.12%1.06%1.07%2.39%3.21%5.11%4.00%
Ex-dateMar 24Aug 18Mar 22Aug 16Mar 31Aug 18Mar 30Aug 17
Payment dateApr 4Aug 29Apr 2Aug 26Apr 8Aug 26Apr 8Aug 25

10 payments since Mar 2022

Ex-dateRecordPaidAmountNote
Aug 17, 2026Aug 17, 2026Aug 25, 2026$0.5792cut from $1.2174
Mar 30, 2026Mar 30, 2026Apr 8, 2026$1.2174raised from $0.5843
Aug 18, 2025Aug 18, 2025Aug 26, 2025$0.5843cut from $1.1426
Mar 31, 2025Mar 31, 2025Apr 8, 2025$1.1426raised from $0.5169
Aug 16, 2024Aug 16, 2024Aug 26, 2024$0.5169cut from $0.9293
Mar 22, 2024Mar 25, 2024Apr 2, 2024$0.9293raised from $0.4382 split-adjusted
Aug 18, 2023Aug 21, 2023Aug 29, 2023$0.8763cut from $1.1806
Mar 24, 2023Mar 27, 2023Apr 4, 2023$1.1806raised from $0.5778
Aug 12, 2022Aug 15, 2022Aug 23, 2022$0.5778cut from $1.0224
Mar 25, 2022Mar 28, 2022Apr 5, 2022$1.0224